Wandercraft completes acquisition of Ekso Bionics
Source publication date
Site published
The October 1 announcement says the purchase of Ekso Bionics, Inc. from a ChronoScale subsidiary was signed and closed simultaneously. Financial terms were not disclosed. Wandercraft intends to continue supporting Atalante X, EksoNR, Eve and Indego Personal.
Summary
Wandercraft announced its acquisition of rehabilitation and personal-mobility exoskeleton developer Ekso Bionics.
Editorial view
Editorial view: the deal brings rehabilitation and personal-mobility product portfolios together.
Evidence and limitations
Party announcement; the deal does not itself establish clinical benefits or expanded product authorizations.